Results of Mohs’ Micrographic Surgery of Periocular Basal Cell Carcinoma: The Swedish Experience
DOI:
https://doi.org/10.2340/actadv.v104.15765Keywords:
basal cell carcinoma, eyelid, Mohs’ micrographic surgery, periocular area, recurrence, skin cancerAbstract
The Department of Ophthalmology, Sahlgrenska University Hospital, has until recently been the only eye clinic in the Nordic countries to perform Mohs’ micrographic surgery of basal cell carcinoma. This has led to the practice of only the most complicated basal cell carcinomas being operated on with this technique. The purpose of this study was to present the results of these surgeries in patients with at least 5 years of follow-up. A retrospective study of all patients operated upon in 2010–2015 was performed. Data were gathered from their medical charts. Primary outcome was recurrence of basal cell carcinoma. One-hundred and sixty-seven patients were operated on. Mohs’ micrographic surgery was used for tumours that were judged as highly aggressive on preoperative biopsy, had ill-defined borders, had recurred after previous surgery, or a combination of these factors. Nine recurrences (5.4% of all radical Mohs’ micrographic surgeries) were diagnosed after a mean postoperative time of 37 months (4–84 months). Interestingly, all of these 9 recurrences after Mohs’ micrographic surgery were in patients who had such surgery because of a recurrent basal cell carcinoma to start with. Good results can be achieved when operating on the most complicated periocular basal cell carcinomas with Mohs’ micrographic surgery but special care has to be taken to ensure radical borders when operating on recurring basal cell carcinomas.
Downloads
References
Gandhi SA, Kampp J. Skin cancer epidemiology, detection, and management. Med Clin North Am 2015; 99: 1323-1335.
https://doi.org/10.1016/j.mcna.2015.06.002 DOI: https://doi.org/10.1016/j.mcna.2015.06.002
Iorio ML, Ter Louw RP, Kauffman CL, Davison SP. Evidence-based medicine: facial skin malignancy. Plast Reconstr Surg 2013; 132: 1631-1643.
https://doi.org/10.1097/PRS.0b013e3182a8085f DOI: https://doi.org/10.1097/PRS.0b013e3182a8085f
Furdova A, Kapitanova K, Kollarova A, Sekac J. Periocular basal cell carcinoma: clinical perspectives. Oncol Rev 2020; 14: 420.
https://doi.org/10.4081/oncol.2020.420 DOI: https://doi.org/10.4081/oncol.2020.420
Moul DK, Chern PL, Shumaker PR, Zelac DE, Greenway HT. Mohs micrographic surgery for eyelid and periorbital skin cancer. Int Ophthalmol Clin 2009; 49: 111-127.
https://doi.org/10.1097/IIO.0b013e3181b80482 DOI: https://doi.org/10.1097/IIO.0b013e3181b80482
Saleh GM, Desai P, Collin JR, Ives A, Jones T, Hussain B. Incidence of eyelid basal cell carcinoma in England: 2000-2010. Br J Ophthalmol 2017; 101: 209-212.
https://doi.org/10.1136/bjophthalmol-2015-308261 DOI: https://doi.org/10.1136/bjophthalmol-2015-308261
Kappelin J, Green AC, Ingvar Å, Ahnlide I, Nielsen K. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study. Br J Dermatol 2022; 186: 963-969.
https://doi.org/10.1111/bjd.20964 DOI: https://doi.org/10.1111/bjd.20964
Paoli J, Daryoni S, Wennberg AM, Mölne L, Gillstedt M, Miocic M, et al. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol 2011; 91: 689-693.
https://doi.org/10.2340/00015555-1134 DOI: https://doi.org/10.2340/00015555-1134
Kakkassery V, Heindl LM. SOP Standardisiertes Vorgehen in der Diagnostik und Therapie des periokulären Basalzellkarzinoms. Klin Monbl Augenheilkd 2017 Oct 9 [Online ahead of print].
https://doi.org/10.1055/s-0043-120086 DOI: https://doi.org/10.1055/s-0043-120086
Rokohl AC, Kopecky A, Guo Y, Kakkassery V, Mor JM, Loreck N, et al. Chirurgische Resektion mit ophthalmoplastischer Rekonstruktion. Goldstandard beim periokulären Basalzellkarzinom. Ophthalmologe 2020; 117: 95-105.
https://doi.org/10.1007/s00347-019-00973-x DOI: https://doi.org/10.1007/s00347-019-00973-x
Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
https://doi.org/10.1111/j.1365-2133.2008.08666.x DOI: https://doi.org/10.1111/j.1365-2133.2008.08666.x
Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, et al. Guidelines of care for Mohs micrographic surgery. J Am Acad Dermatol 1995; 33: 271-278.
https://doi.org/10.1016/0190-9622(95)90261-9 DOI: https://doi.org/10.1016/0190-9622(95)90261-9
Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986; 104: 901-909.
https://doi.org/10.1001/archopht.1986.01050180135046 DOI: https://doi.org/10.1001/archopht.1986.01050180135046
Treacy MP, Wynne NC, Gale JL, Duignan E, Moran B, Flynn AM, et al. Mohs micrographic surgery for periocular skin tumours in Ireland. Ir J Med Sci 2016; 185: 779-783.
https://doi.org/10.1007/s11845-015-1296-3 DOI: https://doi.org/10.1007/s11845-015-1296-3
Monheit G, Hrynewycz K. Mohs surgery for periocular tumors. Dermatol Surg 2019; 45 Suppl 2: S70-s78.
https://doi.org/10.1097/DSS.0000000000002254 DOI: https://doi.org/10.1097/DSS.0000000000002254
Wong E, Axibal E, Brown M. Mohs micrographic surgery. Facial Plast Surg Clin North Am 2019; 27: 15-34.
https://doi.org/10.1016/j.fsc.2018.08.002 DOI: https://doi.org/10.1016/j.fsc.2018.08.002
Sin CW, Barua A, Cook A. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study. Int J Dermatol 2016; 55: 1044-1047.
https://doi.org/10.1111/ijd.13326 DOI: https://doi.org/10.1111/ijd.13326
Malhotra R, Huilgol SC, Huynh NT, Selva D. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004; 111: 631-636.
https://doi.org/10.1016/j.ophtha.2003.11.004 DOI: https://doi.org/10.1016/j.ophtha.2003.11.004
Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face: results of a retrospective study and review of the literature. Br J Dermatol 2004; 151: 141-147.
https://doi.org/10.1111/j.1365-2133.2004.06047.x DOI: https://doi.org/10.1111/j.1365-2133.2004.06047.x
Lindgren G, Lindblom B, Bratel AT, Mölne L, Larkö O. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. I. Characteristics of the tumours and details of the procedure. Acta Ophthalmol Scand 2000; 78: 425-429.
https://doi.org/10.1034/j.1600-0420.2000.078004425.x DOI: https://doi.org/10.1034/j.1600-0420.2000.078004425.x
Lindgren G, Lindblom B, Larkö O. Mohs' micrographic surgery for basal cell carcinomas on the eyelids and medial canthal area. II. Reconstruction and follow-up. Acta Ophthalmol Scand 2000; 78: 430-436.
https://doi.org/10.1034/j.1600-0420.2000.078004430.x DOI: https://doi.org/10.1034/j.1600-0420.2000.078004430.x
Jernbeck J, Glaumann B, Glas JE. [Basal cell carcinoma: clinical evaluation of the histological grading of aggressive types of cancer]. Lakartidningen 1988; 85: 3467-3470 (in Swedish).
Jebodhsingh KN, Calafati J, Farrokhyar F, Harvey JT. Recurrence rates of basal cell carcinoma of the periocular skin: what to do with patients who have positive margins after resection. Can J Ophthalmol 2012; 47: 181-184.
https://doi.org/10.1016/j.jcjo.2012.01.024 DOI: https://doi.org/10.1016/j.jcjo.2012.01.024
Weesie F, Naus NC, Vasilic D, Hollestein LM, van den Bos RR, Wakkee M. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study. Br J Dermatol 2019; 180: 1176-1182.
https://doi.org/10.1111/bjd.17516 DOI: https://doi.org/10.1111/bjd.17516
Barnes EA, Dickinson AJ, Langtry JA, Lawrence CM. The role of Mohs excision in periocular basal cell carcinoma. Br J Ophthalmol 2006; 90: 660-661.
https://doi.org/10.1136/bjo.2006.092429/10.1136/bjo.2006.093187 DOI: https://doi.org/10.1136/bjo.2006.092429/10.1136/bjo.2006.093187
Julian CG, Bowers PW. A prospective study of Mohs' micrographic surgery in two English centres. Br J Dermatol 1997; 136: 515-518. DOI: https://doi.org/10.1111/j.1365-2133.1997.tb02133.x
https://doi.org/10.1046/j.1365-2133.1997.d01-1227.x DOI: https://doi.org/10.1046/j.1365-2133.1997.d01-1227.x
Wennberg AM, Larkö O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999; 79: 370-372.
https://doi.org/10.1080/000155599750010292 DOI: https://doi.org/10.1080/000155599750010292
Eliezri YD, Cohen PR. Cancer recurrence following Mohs micrographic surgery: a mechanism of tumor persistence. Plast Reconstr Surg 1992; 90: 121-125.
https://doi.org/10.1097/00006534-199207000-00020 DOI: https://doi.org/10.1097/00006534-199207000-00020
Dzubow LM. False-negative tumor-free margins following Mohs surgery. J Dermatol Surg Oncol 1988; 14: 600-602.
https://doi.org/10.1111/j.1524-4725.1988.tb03385.x DOI: https://doi.org/10.1111/j.1524-4725.1988.tb03385.x
Smeets NW, Stavast-Kooy AJ, Krekels GA, Daemen MJ, Neumann HA. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. Dermatol Surg 2003; 29: 375-377.
https://doi.org/10.1046/j.1524-4725.2003.29089.x DOI: https://doi.org/10.1046/j.1524-4725.2003.29089.x
Hruza GJ. Mohs micrographic surgery local recurrences. J Dermatol Surg Oncol 1994; 20: 573-577.
https://doi.org/10.1111/j.1524-4725.1994.tb00149.x DOI: https://doi.org/10.1111/j.1524-4725.1994.tb00149.x
Rapini RP. Pitfalls of Mohs micrographic surgery. J Am Acad Dermatol 1990; 22: 681-686.
https://doi.org/10.1016/0190-9622(90)70095-Y DOI: https://doi.org/10.1016/0190-9622(90)70095-Y
Carniciu AL, Jovanovic N, Kahana A. Eyelid complications associated with surgery for periocular cutaneous malignancies. Facial Plast Surg 2020; 36: 166-175.
https://doi.org/10.1055/s-0040-1709515 DOI: https://doi.org/10.1055/s-0040-1709515
Leshin B, Yeatts P, Anscher M, Montano G, Dutton JJ. Management of periocular basal cell carcinoma: Mohs' micrographic surgery versus radiotherapy. Surv Ophthalmol 1993; 38: 193-212.
https://doi.org/10.1016/0039-6257(93)90101-C DOI: https://doi.org/10.1016/0039-6257(93)90101-C
Cho M, Gordon L, Rembielak A, Woo TC. Utility of radiotherapy for treatment of basal cell carcinoma: a review. Br J Dermatol 2014; 171: 968-973.
https://doi.org/10.1111/bjd.13253 DOI: https://doi.org/10.1111/bjd.13253
Strom T, Harrison LB. Radiotherapy for management of basal and squamous cell carcinoma. Curr Probl Cancer 2015; 39: 237-247.
https://doi.org/10.1016/j.currproblcancer.2015.07.003 DOI: https://doi.org/10.1016/j.currproblcancer.2015.07.003
Sun MT, Wu A, Figueira E, Huilgol S, Selva D. Management of periorbital basal cell carcinoma with orbital invasion. Future Oncol 2015; 11: 3003-3010.
https://doi.org/10.2217/fon.15.190 DOI: https://doi.org/10.2217/fon.15.190
Published
How to Cite
License
Copyright (c) 2024 Kalliopi Erripi, Daniel Paussen, Karin Svedberg
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
